Heparin Lock-Flush



Indications and Reactions:

Role Indications Reactions
Primary
Intravenous Catheter Management 18.4%
Indwelling Catheter Management 16.1%
Central Venous Catheterisation 13.8%
Drug Use For Unknown Indication 10.3%
Anticoagulant Therapy 6.9%
Breast Cancer 6.9%
Thrombosis Prophylaxis 6.9%
Osteomyelitis 3.4%
Toe Amputation 3.4%
Cardiac Operation 2.3%
Antibiotic Therapy 1.1%
Hyperemesis Gravidarum 1.1%
Infection Prophylaxis 1.1%
Localised Infection 1.1%
Malnutrition 1.1%
Multiple Myeloma 1.1%
Neoplasm Malignant 1.1%
Neuroborreliosis 1.1%
Preoperative Care 1.1%
Staphylococcal Infection 1.1%
Therapeutic Product Contamination 20.7%
Pharmaceutical Product Complaint 14.6%
Serratia Infection 9.8%
Medication Error 7.3%
Vomiting 7.3%
Heparin-induced Thrombocytopenia 4.9%
Fungal Infection 3.7%
Skin Discolouration 3.7%
Skin Infection 3.7%
Diarrhoea 2.4%
Dyspnoea 2.4%
Nausea 2.4%
Rash 2.4%
Renal Failure 2.4%
Serratia Bacteraemia 2.4%
Stomach Discomfort 2.4%
Thrombophlebitis Superficial 2.4%
Tremor 2.4%
Infection 1.2%
Mesenteric Vein Thrombosis 1.2%
Secondary
Product Used For Unknown Indication 82.1%
Drug Use For Unknown Indication 3.4%
Cardiac Operation 2.3%
Deep Vein Thrombosis 2.3%
Rash 1.7%
Thrombosis Prophylaxis 1.3%
Anticoagulant Therapy 0.8%
Central Venous Catheterisation 0.8%
Indwelling Catheter Management 0.8%
Prophylaxis 0.8%
Intravenous Catheter Management 0.6%
Metastatic Carcinoma Of The Bladder 0.6%
Malnutrition 0.4%
Neoplasm Malignant 0.4%
Therapeutic Procedure 0.4%
Chemotherapy 0.2%
Chest Pain 0.2%
Flushing 0.2%
Nausea 0.2%
Osteomyelitis 0.2%
Heparin-induced Thrombocytopenia 17.5%
Pharmaceutical Product Complaint 17.5%
Vomiting 12.5%
Sepsis 10.0%
Fungal Infection 5.0%
Generalised Oedema 5.0%
Stomach Discomfort 5.0%
Therapeutic Product Contamination 5.0%
Cardiac Output Decreased 2.5%
Cholelithiasis 2.5%
Dizziness 2.5%
Medication Error 2.5%
Pulmonary Embolism 2.5%
Pyrexia 2.5%
Thrombocytopenia 2.5%
Treatment Failure 2.5%
Venous Thrombosis 2.5%
Concomitant
Product Used For Unknown Indication 24.2%
Prophylaxis 11.4%
Nausea 8.8%
Acute Myeloid Leukaemia 6.8%
Drug Use For Unknown Indication 6.8%
Pain 5.5%
Transitional Cell Carcinoma 3.7%
Vomiting 3.5%
Non-small Cell Lung Cancer 3.2%
Infection Prophylaxis 3.1%
Constipation 2.9%
Supplementation Therapy 2.8%
Hepatitis C 2.6%
Multiple Myeloma 2.6%
Blood Pressure 2.5%
Breast Cancer 2.3%
Hypertension 2.0%
Anxiety 1.8%
Hypercalcaemia Of Malignancy 1.8%
Central Venous Catheterisation 1.7%
Vomiting 12.3%
Sepsis 8.6%
Hepatic Enzyme Increased 7.4%
Death 6.2%
Fatigue 6.2%
Pneumonia 6.2%
Vasculitis 6.2%
Diarrhoea 4.9%
Rash 4.9%
Rash Erythematous 4.9%
Renal Failure Acute 4.9%
Tremor 4.9%
Anaemia 3.7%
White Blood Cell Count Decreased 3.7%
Abdominal Pain 2.5%
Brain Oedema 2.5%
Caecitis 2.5%
Cardiac Arrest 2.5%
Confusional State 2.5%
Fungaemia 2.5%